Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science SA (NASDAQ:MLEC), a science-based food ingredient company, has announced it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on October 2, 2024, before market open. The company will host a live Conference Call and webcast on the same day at 08:30 AM ET.
The call will feature CEO Gastón Paladini, CFO José López Lecube, and Chief Science Officer Amit Dhingra. It will include a presentation viewable during the webcast, with a replay and PDF version available afterwards on Moolec's Investor Relations website.
Participants can join via the provided Zoom link or dial-in numbers. The webinar ID is 915 9750 1131, with passcode 799765. International dial-in numbers are also available.
Moolec Science SA (NASDAQ:MLEC), un'azienda che produce ingredienti alimentari basati sulla scienza, ha annunciato che rilascerà il suo Aggiornamento per gli Affari per il Quarto Trimestre e l'Intero Anno Fiscale 2024 il 2 ottobre 2024, prima dell'apertura dei mercati. L'azienda terrà una Conferenza Telefonica dal vivo e un webcast lo stesso giorno alle 08:30 ET.
La chiamata vedrà la partecipazione del CEO Gastón Paladini, del CFO José López Lecube e del Chief Science Officer Amit Dhingra. Ci sarà una presentazione visualizzabile durante il webcast, con una registrazione e una versione PDF disponibili successivamente sul sito web delle Relazioni con gli Investitori di Moolec.
I partecipanti possono unirsi tramite il link Zoom fornito o i numeri di accesso. L'ID del webinar è 915 9750 1131, con codice di accesso 799765. Sono disponibili anche numeri di accesso internazionali.
Moolec Science SA (NASDAQ:MLEC), una empresa de ingredientes alimentarios basada en la ciencia, ha anunciado que publicará su Actualización Empresarial para el Cuarto Trimestre y el Año Fiscal Completo 2024 el 2 de octubre de 2024, antes de la apertura del mercado. La empresa llevará a cabo una Conferencia Telefónica en vivo y un webcast el mismo día a las 08:30 AM ET.
La llamada contará con la participación del CEO Gastón Paladini, del CFO José López Lecube y del Chief Science Officer Amit Dhingra. Incluirá una presentación que se podrá ver durante el webcast, con una repetición y una versión en PDF disponibles posteriormente en el sitio web de Relaciones con Inversores de Moolec.
Los participantes pueden unirse a través del enlace de Zoom proporcionado o de los números de marcado. El ID del webinar es 915 9750 1131, con código de acceso 799765. También hay números de acceso internacionales disponibles.
Moolec Science SA (NASDAQ:MLEC), 과학 기반 식품 원료 회사가 2024년 4분기 및 전체 회계 연도 사업 업데이트를 2024년 10월 2일 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 라이브 컨퍼런스 콜 및 웹캐스트를 진행할 예정입니다.
이번 통화에는 CEO Gastón Paladini, CFO José López Lecube 및 Chief Science Officer Amit Dhingra가 참석할 예정입니다. 웹캐스트 동안 볼 수 있는 프레젠테이션이 포함되며, 이후 Moolec의 투자자 관계 웹사이트에서 재생 및 PDF 버전이 제공됩니다.
참여자는 제공된 Zoom 링크 또는 전화 접속 번호를 통해 참여할 수 있습니다. 웨비나 ID는 915 9750 1131이며, 비밀번호는 799765입니다. 국제 전화 접속 번호도 제공됩니다.
Moolec Science SA (NASDAQ:MLEC), une entreprise d'ingrédients alimentaires basée sur la science, a annoncé qu'elle publiera sa mise à jour d'affaires pour le quatrième trimestre et l'exercice complet 2024 le 2 octobre 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique en direct et un webinaire le même jour à 08h30 ET.
La conférence sera animée par le PDG Gastón Paladini, le directeur financier José López Lecube et le directeur scientifique Amit Dhingra. Elle comprendra une présentation visible lors du webinaire, avec un enregistrement et une version PDF disponibles par la suite sur le site des relations investisseurs de Moolec.
Les participants peuvent rejoindre via le lien Zoom fourni ou les numéros d'appel. L'ID du webinaire est 915 9750 1131, avec le mot de passe 799765. Des numéros d'appel internationaux sont également disponibles.
Moolec Science SA (NASDAQ:MLEC), ein wissenschaftlich orientiertes Lebensmittelzutatenunternehmen, hat angekündigt, dass es sein Geschäftsupdate für das vierte Quartal und das gesamte Geschäftsjahr 2024 am 2. Oktober 2024 vor Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 08:30 Uhr ET eine Live-Konferenzschaltung und ein Webcast veranstalten.
Die Telefonkonferenz wird von CEO Gastón Paladini, CFO José López Lecube und Chief Science Officer Amit Dhingra geleitet. Sie umfasst eine Präsentation, die während des Webcasts sichtbar ist, mit einer Aufnahme und einer PDF-Version, die später auf der Investor Relations-Website von Moolec verfügbar sein werden.
Teilnehmer können über den bereitgestellten Zoom-Link oder die Einwahlnummern teilnehmen. Die Webinar-ID lautet 915 9750 1131, mit dem Zugangscode 799765. Internationale Einwahlnummern sind ebenfalls verfügbar.
- None.
- None.
LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens.
Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.
The Conference Call will be accompanied by a presentation, which can be viewed during the webcast. A replay and the pdf version of the presentation will be available shortly after the conclusion of the live event via the company's Investor Relations website.
Connection Details:
When: October 2, 2024 - 08:30 AM Eastern Time (US and Canada)
Topic: Moolec Science - Business Update Conference Call Q4 and Full Fiscal Year 2024
Link to join the webinar:
https://icrinc.zoom.us/j/91597501131?pwd=dnzbr1Nc4asDmMqsac806jp15Dx84s.1One tap mobile: +13017158592,,91597501131#,,,,*799765# US
Dial In: +1 301 715 8592 | Webinar ID: 915 9750 1131, passcode: 799765
International numbers available: https://icrinc.zoom.us/u/abX5mDiNYZ
About Moolec Science SA
Moolec is a science-based ingredient company leader in the use of Molecular Farming technology for the food and dietary supplementation markets. The Company's mission is to create unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the world produces animal proteins for the good of the planet. Moolec's technological approach aims to have the cost structure of plant-based solutions with the nutrition and functionality of animal-based ones. The Company's technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop for the food industry. Moolec's product portfolio and pipeline leverages the agronomic efficiency of broadly used target crops, like soybean, pea, and safflower to produce oils and proteins. The Company has an industrial and commercial R&D capability to complement their Molecular Farming technology and secures a growing international patent portfolio (25+, both granted and pending) for its technology. Moolec is run by a diverse team of Ph.Ds and Food Insiders, and operates in the United States, Europe, and South America. For more information, visit moolecscience.com and ir.moolecscience.com.
Forward Looking Statements
This press release contains "forward-looking statements." Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header "Risk Factors" in Moolec's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission ("SEC"), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.
Contacts:
Press & Media inquiries: comms@moolecscience.com
Investor Relations inquiries: ir@moolecscience.com | MoolecIR@icrinc.com
Contact Information
Press & Media
comms@moolecscience.com
Investor Relations
ir@moolecscience.com
SOURCE: Moolec Science
View the original press release on newswire.com.
FAQ
When will Moolec Science (MLEC) release its Q4 and FY 2024 Business Update?
What time is Moolec Science's (MLEC) Q4 2024 earnings call?
Who will be presenting at Moolec Science's (MLEC) Q4 2024 conference call?
How can I access Moolec Science's (MLEC) Q4 2024 earnings call?
